Literature DB >> 11414497

Development of goat embryos after in vitro fertilization and parthenogenetic activation by different methods.

E M Ongeri1, C L Bormann, R E Butler, D Melican, W G Gavin, Y Echelard, R L Krisher, E Behboodi.   

Abstract

Effective activation protocols that can be used during nuclear transfer investigations in goats need to be developed. We compared the development of IVF goat embryos with those of nonfertilized parthogenetically developing oocytes activated by treatment with either ionomycin or ethanol, both followed by immediate exposure to 6-diethylaminopurine (6-DMAP). Cumulus oocyte complexes (COCs) recovered from abattoir goat ovaries were either matured in a conventional laboratory incubator or placed in pre-equilibrated maturation medium and shipped overnight in a battery-operated dry incubator to another laboratory. Mature COCs were allocated randomly to one of three treatment groups. Group 1 oocytes (n=169 shipped, n=253 not shipped) were fertilized in vitro at 24 h postmaturation (hpm). The remaining COCs were activated at 28 hpm in either ionomycin (Group 2: n=362 shipped, n=202 not shipped), or ethanol (Group 3: n=263 shipped, n=249 not shipped). Activated oocytes were immediately incubated in 6-DMAP for 4 h. Blastocyst development was evaluated on Day 8 post-insemination/activation. Percent cleavage was comparable in shipped and nonshipped oocytes and in all treatment groups. In both shipped and nonshipped oocytes, parthenotes developing from ionomycin- and ethanol-activated oocytes had significantly greater blastocyst development (P<0.01) compared to IVF embryos (28.5 +/- 3.0, 27.4 +/- 2.8, 10.3 +/- 3.0, respectively for the nonshipped oocytes and 9.9 +/- 2.1, 10.3 +/- 2.4, 3.7 +/- 4.7 respectively for the shipped oocytes). Shipped oocytes had lower blastocyst development compared to nonshipped oocytes in the three treatment groups. The mean blastocyst cell number was not statistically different between shipped and nonshipped oocytes or among treatment groups, suggesting that all were equally viable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414497     DOI: 10.1016/s0093-691x(01)00534-9

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  6 in total

1.  Development of parthenote following in vivo transfer of embryos in Capra hircus.

Authors:  Suresh Dinkar Kharche; Anil Kumar Goel; Satish Kumar Jindal; Ravi Ranjan; Pramod Kumar Rout; Sudhir Kumar Agarwal; Puja Goel; Sonia Saraswat; Ramesh Kumar Vijh; Dhruba Malakar; Sadhan Bag; Bikash Sarkhel; Subrat Kumar Bhanja
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-10-01       Impact factor: 2.416

2.  Calcium ionophore enhanced developmental competence and apoptotic dynamics of goat parthenogenetic embryos produced in vitro.

Authors:  Diksha Dua; D Nagoorvali; M S Chauhan; P Palta; P Mathur; M K Singh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-02-08       Impact factor: 2.416

3.  A comparative study of parthenogenetic activation and in vitro fertilization of in vitro matured caprine oocytes.

Authors:  J Kouamo; S D Kharche
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

4.  Effect of different activators on development of activated in vitro matured caprine oocytes.

Authors:  J R Sharma; S Agarwal; S D Kharche; A K Goel; S K Jindal; S K Agarwal
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

5.  Effects of different activation protocols on cleavage rate and blastocyst production of caprine oocytes.

Authors:  J Pathak; S D Kharche; A Goel
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

6.  Survivability of parthenogenetic embryos following in vivo transfer in naturally synchronized Capra hircus.

Authors:  Ravi Ranjan; Rakesh Kumar Singh; Thirupathi Yasotha; Manish Kumar; Kuldeep Kumar; Renu Singh; Monzamul Houque; Vijay Prakash Mourya; Gyanendra Singh; Mihir Sarkar; Bikash Chandra Das; Sadhan Bag
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-06-06       Impact factor: 2.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.